Consolidated Statement Of Cash Flows

HISAMITSU PHARMACEUTICAL CO.,INC. - Filing #7543334

Concept 2023-03-01 to
2023-08-31
As at
2023-08-31
As at
2023-02-28
As at
2022-08-31
2022-03-01 to
2022-08-31
As at
2022-02-28
Consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Profit (loss) before income taxes
11,638,000,000 JPY
8,935,000,000 JPY
Depreciation
2,473,000,000 JPY
2,160,000,000 JPY
Increase (decrease) in allowance for doubtful accounts
14,000,000 JPY
-68,000,000 JPY
Interest and dividend income
-1,695,000,000 JPY
-704,000,000 JPY
Interest expenses
7,000,000 JPY
4,000,000 JPY
Increase (decrease) in retirement benefit liability
72,000,000 JPY
187,000,000 JPY
Share of loss (profit) of entities accounted for using equity method
22,000,000 JPY
69,000,000 JPY
Subtotal
8,274,000,000 JPY
10,179,000,000 JPY
Decrease (increase) in trade receivables
-248,000,000 JPY
3,598,000,000 JPY
Income taxes paid
-1,906,000,000 JPY
-2,881,000,000 JPY
Decrease (increase) in inventories
-342,000,000 JPY
-1,704,000,000 JPY
Net cash provided by (used in) operating activities
7,851,000,000 JPY
8,162,000,000 JPY
Increase (decrease) in trade payables
1,079,000,000 JPY
1,857,000,000 JPY
Other, net
-4,792,000,000 JPY
-4,157,000,000 JPY
Interest and dividends received
1,499,000,000 JPY
870,000,000 JPY
Interest paid
-7,000,000 JPY
-4,000,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-4,686,000,000 JPY
-2,341,000,000 JPY
Net cash provided by (used in) investing activities
10,443,000,000 JPY
-17,928,000,000 JPY
Purchase of investment securities
-8,000,000 JPY
-5,507,000,000 JPY
Proceeds from sale of investment securities
JPY
30,000,000 JPY
Other, net
1,000,000 JPY
346,000,000 JPY
Cash flows from financing activities
Purchase of treasury shares
-1,336,000,000 JPY
0 JPY
Dividends paid
-3,287,000,000 JPY
-3,357,000,000 JPY
Dividends paid to non-controlling interests
-108,000,000 JPY
-61,000,000 JPY
Repayments of long-term borrowings
-33,000,000 JPY
-35,000,000 JPY
Net cash provided by (used in) financing activities
-4,841,000,000 JPY
-3,641,000,000 JPY
Other, net
-73,000,000 JPY
-185,000,000 JPY
Effect of exchange rate change on cash and cash equivalents
2,307,000,000 JPY
5,932,000,000 JPY
Net increase (decrease) in cash and cash equivalents
15,761,000,000 JPY
-7,475,000,000 JPY
Cash and cash equivalents
81,186,000,000 JPY
65,424,000,000 JPY
78,771,000,000 JPY
86,247,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.